May 2011 Briefing - Allergy
Here are what the editors at HealthDay consider to be the most important developments in Allergy for May 2011. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice.
Effect Estimates May Be Inflated in Biomarker Studies
TUESDAY, May 31 (HealthDay News) -- Biomarker effects are often overestimated in highly cited studies compared to the effects reported in subsequent meta-analyses of the same associations, according to a review published in the June 1 issue of the Journal of the American Medical Association.
Frequent Bronchoconstriction Tied to Airway Remodeling
THURSDAY, May 26 (HealthDay News) -- Experimentally induced bronchoconstriction may promote airway remodeling in patients with asthma, according to a study published in the May 26 issue of the New England Journal of Medicine.
Contact With Drug Industry Linked to Positive Attitudes
WEDNESDAY, May 25 (HealthDay News) -- The extent of contact that medical students have with the pharmaceutical industry is associated with positive attitudes about marketing, according to a review published online May 24 in PLoS Medicine.
Inappropriate Antibiotic Prescribing Common in Asthma
MONDAY, May 23 (HealthDay News) -- Inappropriate antibiotic prescribing appears to be relatively common among children with asthma, according to two studies published online May 23 in Pediatrics.
Many Medical Students Lack Confidence in Medical Law
FRIDAY, May 20 (HealthDay News) -- The majority of medical students lack confidence in their knowledge and skills across many areas of medical law, according to a study published online May 16 in the Journal of Medical Ethics.
Childhood Eczema, Rhinitis Predict Adult Asthma
FRIDAY, May 13 (HealthDay News) -- Children who have eczema and rhinitis may be more susceptible to atopic asthma in adulthood, according to research published online April 4 in the Journal of Allergy and Clinical Immunology.
Medical Education Participants Recognize Funding Bias
WEDNESDAY, May 11 (HealthDay News) -- Although most medical professionals believe that commercial funding of continuing medical education (CME) introduces bias, most are not willing to pay higher fees to offset or eliminate such funding sources, according to a study published in the May 9 issue of the Archives of Internal Medicine.
Adding Omalizumab May Improve Uncontrolled Asthma
FRIDAY, May 6 (HealthDay News) -- Omalizumab appears to provide additional clinical benefits in patients with severe allergic asthma that is inadequately controlled with inhaled corticosteroids (ICS) and long-acting beta2-agonists (LABAs), according to a study published in the May 3 issue of the Annals of Internal Medicine.
Leukotriene-Receptor Antagonists Effective in Asthma
WEDNESDAY, May 4 (HealthDay News) -- Use of a leukotriene-receptor antagonist (LTRA) may be as effective as an inhaled glucocorticoid as first-line controller therapy, and as effective as a long-acting beta2-agonist (LABA) as an add-on therapy, for the treatment of asthma patients, according to the findings of two pragmatic trials published in the May 5 issue of the New England Journal of Medicine.
CDC: Asthma Prevalence on the Rise in United States
TUESDAY, May 3 (HealthDay News) -- The prevalence of asthma among both adults and children has increased in the last decade, and asthma costs have increased in recent years as well, according to a report in the May 3 early-release issue of the U.S. Centers for Disease Control and Prevention's Morbidity and Mortality Weekly Report.